UniProt ID | U2AF2_HUMAN | |
---|---|---|
UniProt AC | P26368 | |
Protein Name | Splicing factor U2AF 65 kDa subunit | |
Gene Name | U2AF2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 475 | |
Subcellular Localization | Nucleus. | |
Protein Description | Plays a role in pre-mRNA splicing and 3'-end processing. [PubMed: 17024186 By recruiting PRPF19 and the PRP19C/Prp19 complex/NTC/Nineteen complex to the RNA polymerase II C-terminal domain (CTD), and thereby pre-mRNA, may couple transcription to splicing] | |
Protein Sequence | MSDFDEFERQLNENKQERDKENRHRKRSHSRSRSRDRKRRSRSRDRRNRDQRSASRDRRRRSKPLTRGAKEEHGGLIRSPRHEKKKKVRKYWDVPPPGFEHITPMQYKAMQAAGQIPATALLPTMTPDGLAVTPTPVPVVGSQMTRQARRLYVGNIPFGITEEAMMDFFNAQMRLGGLTQAPGNPVLAVQINQDKNFAFLEFRSVDETTQAMAFDGIIFQGQSLKIRRPHDYQPLPGMSENPSVYVPGVVSTVVPDSAHKLFIGGLPNYLNDDQVKELLTSFGPLKAFNLVKDSATGLSKGYAFCEYVDINVTDQAIAGLNGMQLGDKKLLVQRASVGAKNATLVSPPSTINQTPVTLQVPGLMSSQVQMGGHPTEVLCLMNMVLPEELLDDEEYEEIVEDVRDECSKYGLVKSIEIPRPVDGVEVPGCGKIFVEFTSVFDCQKAMQGLTGRKFANRVVVTKYCDPDSYHRRDFW | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSDFDEFER ------CCCHHHHHH | 47.16 | 29255136 | |
2 | Acetylation | ------MSDFDEFER ------CCCHHHHHH | 47.16 | 20068231 | |
15 | Sumoylation | ERQLNENKQERDKEN HHHHHHHHHHHHHHH | 47.56 | 28112733 | |
15 | Ubiquitination | ERQLNENKQERDKEN HHHHHHHHHHHHHHH | 47.56 | 33845483 | |
15 | Hydroxylation | ERQLNENKQERDKEN HHHHHHHHHHHHHHH | 47.56 | 19574390 | |
20 | Ubiquitination | ENKQERDKENRHRKR HHHHHHHHHHHHHHH | 64.21 | 24816145 | |
28 | Phosphorylation | ENRHRKRSHSRSRSR HHHHHHHHHHHHHHH | 28.93 | 23882029 | |
30 | Phosphorylation | RHRKRSHSRSRSRDR HHHHHHHHHHHHHHH | 32.95 | 23882029 | |
32 | Phosphorylation | RKRSHSRSRSRDRKR HHHHHHHHHHHHHHH | 37.31 | 20068231 | |
34 | Phosphorylation | RSHSRSRSRDRKRRS HHHHHHHHHHHHHHH | 39.52 | 20068231 | |
41 | Phosphorylation | SRDRKRRSRSRDRRN HHHHHHHHHHHHHHH | 38.34 | 20068231 | |
43 | Phosphorylation | DRKRRSRSRDRRNRD HHHHHHHHHHHHHHH | 39.52 | 20068231 | |
53 | Phosphorylation | RRNRDQRSASRDRRR HHHHHHHHHHHHHHH | 25.59 | 20068231 | |
55 | Phosphorylation | NRDQRSASRDRRRRS HHHHHHHHHHHHHHH | 35.64 | 20068231 | |
61 | Ubiquitination | ASRDRRRRSKPLTRG HHHHHHHHHCCCCCC | 47.42 | 22053931 | |
62 | Phosphorylation | SRDRRRRSKPLTRGA HHHHHHHHCCCCCCC | 36.49 | 20068231 | |
66 | Phosphorylation | RRRSKPLTRGAKEEH HHHHCCCCCCCHHHC | 35.27 | 23312004 | |
67 | Methylation | RRSKPLTRGAKEEHG HHHCCCCCCCHHHCC | 51.24 | 54560449 | |
70 | Ubiquitination | KPLTRGAKEEHGGLI CCCCCCCHHHCCCCC | 67.47 | 33845483 | |
70 | 2-Hydroxyisobutyrylation | KPLTRGAKEEHGGLI CCCCCCCHHHCCCCC | 67.47 | - | |
70 | Sumoylation | KPLTRGAKEEHGGLI CCCCCCCHHHCCCCC | 67.47 | 28112733 | |
70 | Acetylation | KPLTRGAKEEHGGLI CCCCCCCHHHCCCCC | 67.47 | 19608861 | |
70 | Sumoylation | KPLTRGAKEEHGGLI CCCCCCCHHHCCCCC | 67.47 | - | |
79 | Phosphorylation | EHGGLIRSPRHEKKK HCCCCCCCCCHHHCC | 21.20 | 29255136 | |
84 | Ubiquitination | IRSPRHEKKKKVRKY CCCCCHHHCCCHHHH | 64.86 | 24816145 | |
119 | Phosphorylation | AAGQIPATALLPTMT HCCCCCCCEECCEEC | 16.69 | 25850435 | |
121 | Ubiquitination | GQIPATALLPTMTPD CCCCCCEECCEECCC | 5.24 | 22053931 | |
122 | Ubiquitination | QIPATALLPTMTPDG CCCCCEECCEECCCC | 2.84 | 21890473 | |
124 | Phosphorylation | PATALLPTMTPDGLA CCCEECCEECCCCCE | 33.38 | 25850435 | |
126 | Phosphorylation | TALLPTMTPDGLAVT CEECCEECCCCCEEC | 22.24 | 25106551 | |
133 | Phosphorylation | TPDGLAVTPTPVPVV CCCCCEECCCCCCCC | 18.81 | 28176443 | |
135 | Phosphorylation | DGLAVTPTPVPVVGS CCCEECCCCCCCCCC | 27.79 | 25850435 | |
142 | Phosphorylation | TPVPVVGSQMTRQAR CCCCCCCCHHHHHHH | 12.74 | 25850435 | |
145 | Phosphorylation | PVVGSQMTRQARRLY CCCCCHHHHHHHHEE | 16.40 | 25850435 | |
182 | Ubiquitination | LGGLTQAPGNPVLAV HCCCCCCCCCCEEEE | 33.02 | 21890473 | |
195 | Methylation | AVQINQDKNFAFLEF EEEECCCCCEEEEEE | 44.17 | 116265267 | |
195 | Ubiquitination | AVQINQDKNFAFLEF EEEECCCCCEEEEEE | 44.17 | 33845483 | |
225 | Ubiquitination | IFQGQSLKIRRPHDY EECCCEEEECCCCCC | 39.14 | 22053931 | |
232 | Phosphorylation | KIRRPHDYQPLPGMS EECCCCCCCCCCCCC | 14.70 | 24144214 | |
239 | Phosphorylation | YQPLPGMSENPSVYV CCCCCCCCCCCCEEC | 39.89 | 24144214 | |
243 | Phosphorylation | PGMSENPSVYVPGVV CCCCCCCCEECCCEE | 37.35 | 24144214 | |
245 | Phosphorylation | MSENPSVYVPGVVST CCCCCCEECCCEEEE | 12.79 | 27642862 | |
251 | Phosphorylation | VYVPGVVSTVVPDSA EECCCEEEEECCCCC | 17.06 | 24144214 | |
252 | Phosphorylation | YVPGVVSTVVPDSAH ECCCEEEEECCCCCH | 17.57 | 24144214 | |
257 | Phosphorylation | VSTVVPDSAHKLFIG EEEECCCCCHHHHCC | 26.63 | 24144214 | |
260 | Ubiquitination | VVPDSAHKLFIGGLP ECCCCCHHHHCCCCC | 44.82 | 29967540 | |
267 | Ubiquitination | KLFIGGLPNYLNDDQ HHHCCCCCCCCCHHH | 30.60 | 21963094 | |
269 | Phosphorylation | FIGGLPNYLNDDQVK HCCCCCCCCCHHHHH | 12.63 | - | |
276 | Hydroxylation | YLNDDQVKELLTSFG CCCHHHHHHHHHHCC | 36.69 | 19574390 | |
276 | Ubiquitination | YLNDDQVKELLTSFG CCCHHHHHHHHHHCC | 36.69 | 33845483 | |
280 | Phosphorylation | DQVKELLTSFGPLKA HHHHHHHHHCCCHHH | 34.33 | - | |
281 | Phosphorylation | QVKELLTSFGPLKAF HHHHHHHHCCCHHHH | 28.33 | 20068231 | |
286 (in isoform 2) | Ubiquitination | - | 54.81 | 21890473 | |
286 (in isoform 1) | Ubiquitination | - | 54.81 | 21890473 | |
286 | Ubiquitination | LTSFGPLKAFNLVKD HHHCCCHHHHHHHCC | 54.81 | 22817900 | |
292 | Succinylation | LKAFNLVKDSATGLS HHHHHHHCCCCCCCC | 49.48 | 23954790 | |
292 | Acetylation | LKAFNLVKDSATGLS HHHHHHHCCCCCCCC | 49.48 | 26051181 | |
292 | 2-Hydroxyisobutyrylation | LKAFNLVKDSATGLS HHHHHHHCCCCCCCC | 49.48 | - | |
292 | Ubiquitination | LKAFNLVKDSATGLS HHHHHHHCCCCCCCC | 49.48 | 32142685 | |
294 | Phosphorylation | AFNLVKDSATGLSKG HHHHHCCCCCCCCCC | 23.24 | 25159151 | |
296 | Phosphorylation | NLVKDSATGLSKGYA HHHCCCCCCCCCCEE | 42.48 | 23403867 | |
298 | Ubiquitination | VKDSATGLSKGYAFC HCCCCCCCCCCEEEE | 4.09 | 23000965 | |
299 | Phosphorylation | KDSATGLSKGYAFCE CCCCCCCCCCEEEEE | 25.94 | 23403867 | |
327 | Ubiquitination | LNGMQLGDKKLLVQR CCCCCCCCCEEEEEC | 54.21 | 21963094 | |
343 | Phosphorylation | SVGAKNATLVSPPST CCCCCCCEEECCCCC | 36.77 | 26074081 | |
346 | Phosphorylation | AKNATLVSPPSTINQ CCCCEEECCCCCCCC | 33.92 | 26074081 | |
349 | Phosphorylation | ATLVSPPSTINQTPV CEEECCCCCCCCCCE | 45.35 | 26074081 | |
350 | Phosphorylation | TLVSPPSTINQTPVT EEECCCCCCCCCCEE | 29.71 | 26074081 | |
354 | Phosphorylation | PPSTINQTPVTLQVP CCCCCCCCCEEEECC | 18.42 | 26074081 | |
358 | Ubiquitination | INQTPVTLQVPGLMS CCCCCEEEECCCCCC | 5.00 | 23000965 | |
404 | Ubiquitination | EIVEDVRDECSKYGL HHHHHHHHHHHHHCC | 62.19 | 32015554 | |
408 | Ubiquitination | DVRDECSKYGLVKSI HHHHHHHHHCCEEEE | 55.80 | 32015554 | |
408 | 2-Hydroxyisobutyrylation | DVRDECSKYGLVKSI HHHHHHHHHCCEEEE | 55.80 | - | |
409 | Ubiquitination | VRDECSKYGLVKSIE HHHHHHHHCCEEEEE | 10.21 | 32015554 | |
413 | Ubiquitination | CSKYGLVKSIEIPRP HHHHCCEEEEECCCC | 51.24 | 32015554 | |
413 | Acetylation | CSKYGLVKSIEIPRP HHHHCCEEEEECCCC | 51.24 | 25953088 | |
413 | 2-Hydroxyisobutyrylation | CSKYGLVKSIEIPRP HHHHCCEEEEECCCC | 51.24 | - | |
414 | Phosphorylation | SKYGLVKSIEIPRPV HHHCCEEEEECCCCC | 20.27 | 21712546 | |
427 | Ubiquitination | PVDGVEVPGCGKIFV CCCCEECCCCCEEEE | 20.89 | 21963094 | |
429 | Glutathionylation | DGVEVPGCGKIFVEF CCEECCCCCEEEEEE | 4.03 | 22555962 | |
431 | Ubiquitination | VEVPGCGKIFVEFTS EECCCCCEEEEEEEE | 36.73 | 21963094 | |
437 | Phosphorylation | GKIFVEFTSVFDCQK CEEEEEEEEHHHHHH | 15.52 | 21712546 | |
442 | Glutathionylation | EFTSVFDCQKAMQGL EEEEHHHHHHHHCCC | 2.80 | 22555962 | |
450 | Phosphorylation | QKAMQGLTGRKFANR HHHHCCCCCCCCCCE | 41.59 | 20068231 | |
457 | Methylation | TGRKFANRVVVTKYC CCCCCCCEEEEEEEC | 21.12 | 115919221 | |
458 | Acetylation | GRKFANRVVVTKYCD CCCCCCEEEEEEECC | 3.99 | 19608861 | |
458 | Ubiquitination | GRKFANRVVVTKYCD CCCCCCEEEEEEECC | 3.99 | 23000965 | |
462 | Ubiquitination | ANRVVVTKYCDPDSY CCEEEEEEECCCCCC | 32.07 | 23000965 | |
462 | Acetylation | ANRVVVTKYCDPDSY CCEEEEEEECCCCCC | 32.07 | 25825284 | |
463 | Phosphorylation | NRVVVTKYCDPDSYH CEEEEEEECCCCCCC | 7.85 | 28152594 | |
464 | Glutathionylation | RVVVTKYCDPDSYHR EEEEEEECCCCCCCC | 6.97 | 22555962 | |
468 | Phosphorylation | TKYCDPDSYHRRDFW EEECCCCCCCCCCCC | 28.38 | 28152594 | |
469 | Phosphorylation | KYCDPDSYHRRDFW- EECCCCCCCCCCCC- | 13.51 | 28152594 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
79 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of U2AF2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-70 AND LYS-462, AND MASSSPECTROMETRY. | |
Hydroxylation | |
Reference | PubMed |
"Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associatedwith RNA splicing."; Webby C.J., Wolf A., Gromak N., Dreger M., Kramer H., Kessler B.,Nielsen M.L., Schmitz C., Butler D.S., Yates J.R. III, Delahunty C.M.,Hahn P., Lengeling A., Mann M., Proudfoot N.J., Schofield C.J.,Boettger A.; Science 325:90-93(2009). Cited for: FUNCTION, AND HYDROXYLATION AT LYS-15 AND LYS-276. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-79, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-79, AND MASSSPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-79, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-79, AND MASSSPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-79, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-53; SER-55 ANDSER-79, AND MASS SPECTROMETRY. | |
"Global phosphoproteome analysis on human HepG2 hepatocytes usingreversed-phase diagonal LC."; Gevaert K., Staes A., Van Damme J., De Groot S., Hugelier K.,Demol H., Martens L., Goethals M., Vandekerckhove J.; Proteomics 5:3589-3599(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2, AND MASSSPECTROMETRY. |